In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk
- PMID: 33395342
- DOI: 10.7326/ACPJ202101190-009
In women, bisphosphonate use for ≥3 years vs. <3 months was linked to increased atypical femur fracture risk
Abstract
Black DM, Geiger EJ, Eastell R, et al. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383:743-53. 32813950.
Comment on
-
Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.N Engl J Med. 2020 Aug 20;383(8):743-753. doi: 10.1056/NEJMoa1916525. N Engl J Med. 2020. PMID: 32813950 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical